Pillar VC’s Post

We're thrilled by the incredible success of our Boston Demo Day event last Tuesday. It was a day filled with exciting tech, top notch pitches, and networking to wrap up this years Nucleate Boston Activator Program. We extend our heartfelt thanks to all who attended and made it unforgettable – we hope you enjoyed it as much as we did! After thorough deliberation, our esteemed judges, Ann DeWitt, Peter Barrett, and Mariela Jaskelioff, determined this year's awardees🌟: ✨ 🏆 Boston Activator 1st Place 🏆 ✨: KiraGen Bio 🏆 MilliporeSigma Regional High Impact Culture Award: AbscoTx 🏆 Genentech Regional Diversity, Equity, and Inclusion Prize: Four-Fourty 🏆 Alnylam Pharmaceuticals Regional Scientific Excellence Award: Neoclease 🏆 UMassM2D2 Lab Space Prize: MabLab The pitches were fantastic and every team should be exceptionally proud of their hard work throughout this Nucleate Activator cycle! We are incredibly thankful to our Semi-Finalist Judges: Iva Toudjarska, Jeff Knox, Jeff Stevens, Jennifer Griffin, Julius Knowles, Michael Fenn, Ph.D., Seo Lee, Andrew Hedin, Stacy Swider, Taewon Yoon, and Vinit Nijhawan (he/him). Thank you to our mentors, experts, and sponsors whose support made this event possible. This includes Novo Nordisk, New England Biolabs, Banc of California, Sanofi, Wyss Institute at Harvard University, and Breakout Ventures, who sponsored our Activator cycle this year. Demo Day was hosted by The Engine and supported by Excedr, EOS Bioinnovation, Biological Design Center, UMass Chan Medical School, and UMassM2D2. We also want to highlight the invaluable contributions of our HQ platinum sponsors: Eli Lilly and Company, Genentech, Pillar VC, Alnylam Pharmaceuticals, BlueYard Capital, and MilliporeSigma. Stay tuned for more updates, photos, and details about our upcoming Phase 6 Summit in August! Ticket link here: https://lnkd.in/esBbe8-5 📸 Caroline Steingard, PhD